Literature DB >> 30256621

Retroelement-Based Genome Editing and Evolution.

Anna J Simon, Barrett R Morrow, Andrew D Ellington.   

Abstract

While several genome editing methods exist, few are suitable for the continuous evolution of targeted sequences.  Here we develop bacterial retroelements known as "retrons" for the dynamic,  in vivo editing and mutagenesis of targeted genes. We first optimized retrons' ability to introduce preprogrammed mutations, optimizing both their expression and the host machinery that interacts with them to increase the incorporation frequency of mutations 78-fold over rates previously reported in synthetic systems. The optimized system is capable of simultaneously overwriting 13 separate positions spanning  a 31-base length, and is for the first time shown to yield targeted deletions and insertions. To engineer retrons as a tool to introduce novel, unprogrammed mutations in specific targeted regions, we expressed them under a mutagenic T7 RNA polymerase. This coupled mutagenic T7 RNA polymerase-retron system enabled the evolution of diverse variants of environmentally selected antibiotic resistance genes, producing mutation rates in the targeted region 190-fold higher than  background cellular mutation rates, potentially enabling the dynamic, continuous self-evolution of selected phenotypes.

Keywords:  continuous evolution; genome editing; polymerase; retron; synthetic biology

Mesh:

Substances:

Year:  2018        PMID: 30256621     DOI: 10.1021/acssynbio.8b00273

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  14 in total

1.  Tools and systems for evolutionary engineering of biomolecules and microorganisms.

Authors:  Sungho Jang; Minsun Kim; Jaeseong Hwang; Gyoo Yeol Jung
Journal:  J Ind Microbiol Biotechnol       Date:  2019-05-27       Impact factor: 3.346

Review 2.  The developing toolkit of continuous directed evolution.

Authors:  Mary S Morrison; Christopher J Podracky; David R Liu
Journal:  Nat Chem Biol       Date:  2020-05-22       Impact factor: 15.040

3.  Recombineering and MAGE.

Authors:  Timothy M Wannier; Peter N Ciaccia; Andrew D Ellington; Gabriel T Filsinger; Farren J Isaacs; Kamyab Javanmardi; Michaela A Jones; Aditya M Kunjapur; Akos Nyerges; Csaba Pal; Max G Schubert; George M Church
Journal:  Nat Rev Methods Primers       Date:  2021-01-14

4.  Improved bacterial recombineering by parallelized protein discovery.

Authors:  Timothy M Wannier; Akos Nyerges; Helene M Kuchwara; Márton Czikkely; Dávid Balogh; Gabriel T Filsinger; Nathaniel C Borders; Christopher J Gregg; Marc J Lajoie; Xavier Rios; Csaba Pál; George M Church
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-28       Impact factor: 11.205

Review 5.  Synthetic evolution.

Authors:  Anna J Simon; Simon d'Oelsnitz; Andrew D Ellington
Journal:  Nat Biotechnol       Date:  2019-06-17       Impact factor: 54.908

6.  High-throughput functional variant screens via in vivo production of single-stranded DNA.

Authors:  Max G Schubert; Daniel B Goodman; Timothy M Wannier; Divjot Kaur; Fahim Farzadfard; Timothy K Lu; Seth L Shipman; George M Church
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

Review 7.  Retrons and their applications in genome engineering.

Authors:  Anna J Simon; Andrew D Ellington; Ilya J Finkelstein
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

8.  Plasmid hypermutation using a targeted artificial DNA replisome.

Authors:  Xiao Yi; Joleen Khey; Romas J Kazlauskas; Michael Travisano
Journal:  Sci Adv       Date:  2021-07-16       Impact factor: 14.136

Review 9.  Genome editor-directed in vivo library diversification.

Authors:  Cristina Cheng; Mi Zhou; Qiwen Su; Alexandra Steigmeyer; Jia Niu
Journal:  Cell Chem Biol       Date:  2021-06-08       Impact factor: 9.039

Review 10.  Targeted mutagenesis of multiple chromosomal regions in microbes.

Authors:  Bálint Csörgő; Akos Nyerges; Csaba Pál
Journal:  Curr Opin Microbiol       Date:  2020-06-26       Impact factor: 7.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.